Miriam Provost

Insider Reports History

Location
Andover, MA
Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Miriam Provost:

Company Role Class Num Shares Value Price $ Report Date Ownership
TransMedics Group, Inc. VP, Global Regulatory Affairs Common Stock 23,348 $2,103,421 $90.09 15 Dec 2023 Direct
TransMedics Group, Inc. VP, Global Regulatory Affairs Stock Option (Right to Buy) 7,813 13 Dec 2023 Direct

Insider Reports Filed by Miriam Provost

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TMDX TransMedics Group, Inc. 13 Dec 2023 10 -$56,648 4 VP, Global Regulatory Affairs 15 Dec 2023, 17:31
TMDX TransMedics Group, Inc. 31 Aug 2023 5 -$32,279 4 VP, Global Regulatory Affairs 05 Sep 2023, 17:36
TMDX TransMedics Group, Inc. 20 Feb 2023 2 $0 4 VP, Global Regulatory Affairs 22 Feb 2023, 19:01
TMDX TransMedics Group, Inc. 13 Dec 2022 4 -$42,191 4 VP, Global Regulatory Affairs 15 Dec 2022, 15:30
TMDX TransMedics Group, Inc. 02 Sep 2022 8 -$33,295 4 VP, Global Regulatory Affairs 13 Dec 2022, 15:30
TMDX TransMedics Group, Inc. 22 Feb 2022 1 $0 4 VP of Global Regl. Affairs 24 Feb 2022, 16:47
TMDX TransMedics Group, Inc. 23 Dec 2021 2 +$2,846 4 VP of US Regulatory & FDA Rel. 28 Dec 2021, 15:30
TMDX TransMedics Group, Inc. 15 Sep 2021 3 -$30,718 4 VP of US Regulatory & FDA Rel. 17 Sep 2021, 16:34
TMDX TransMedics Group, Inc. 30 Jul 2021 2 +$7,103 4 VP of US Regulatory & FDA Rel. 03 Aug 2021, 17:00